Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9786) 9786
Publication (897) 897
Newsletter (475) 475
Newspaper Article (463) 463
Book Chapter (129) 129
Book Review (110) 110
Book / eBook (69) 69
Dissertation (23) 23
Conference Proceeding (22) 22
Magazine Article (17) 17
Web Resource (15) 15
Trade Publication Article (12) 12
Reference (3) 3
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7153) 7153
index medicus (4451) 4451
female (3825) 3825
male (3717) 3717
middle aged (3290) 3290
pancreatic neoplasms - pathology (2951) 2951
pancreatic cancer (2687) 2687
aged (2616) 2616
adult (2609) 2609
tumors (2168) 2168
oncology (2078) 2078
cancer (2004) 2004
surgery (1901) 1901
pancreas (1896) 1896
neuroendocrine tumors (1699) 1699
pancreatic neoplasms - surgery (1589) 1589
pancreatic neoplasms - diagnosis (1531) 1531
gastroenterology & hepatology (1416) 1416
diagnosis (1344) 1344
neuroendocrine tumors - pathology (1337) 1337
prognosis (1186) 1186
metastasis (1130) 1130
research (1104) 1104
retrospective studies (1048) 1048
animals (1028) 1028
pancreatic neoplasms - diagnostic imaging (1024) 1024
aged, 80 and over (1006) 1006
endocrinology & metabolism (987) 987
treatment outcome (947) 947
pathology (931) 931
immunohistochemistry (916) 916
pancreatic neoplasms - metabolism (889) 889
management (841) 841
care and treatment (840) 840
survival (807) 807
pancreatic neoplasms - drug therapy (773) 773
neuroendocrine tumors - diagnosis (771) 771
pancreatic neoplasms - genetics (763) 763
medicine & public health (753) 753
endocrine tumors (741) 741
expression (680) 680
diagnosis, differential (672) 672
neuroendocrine tumors - surgery (670) 670
pancreatic neoplasms - therapy (670) 670
tomography, x-ray computed (666) 666
chemotherapy (644) 644
carcinoma (636) 636
neoplasms (608) 608
patients (596) 596
adolescent (594) 594
liver neoplasms - secondary (593) 593
analysis (575) 575
young adult (571) 571
pancreatic neoplasms - mortality (565) 565
health aspects (556) 556
neoplasm staging (553) 553
adenocarcinoma (546) 546
pancreatic neuroendocrine tumors (521) 521
neuroendocrine tumors - drug therapy (516) 516
pancreatectomy (513) 513
neuroendocrine tumor (502) 502
radiology, nuclear medicine & medical imaging (497) 497
neuroendocrine tumors - diagnostic imaging (494) 494
mice (485) 485
abridged index medicus (476) 476
neuroendocrine tumors - metabolism (470) 470
pancreas - pathology (455) 455
pancreatic neoplasms - complications (448) 448
risk factors (447) 447
medicine (445) 445
pancreatic neuroendocrine tumor (445) 445
magnetic resonance imaging (442) 442
neuroendocrine tumors - therapy (441) 441
follow-up studies (433) 433
insulinoma (425) 425
prognostic-factors (418) 418
pancreaticoduodenectomy (414) 414
resection (408) 408
cancer therapies (402) 402
medical prognosis (400) 400
article (395) 395
antineoplastic agents - therapeutic use (390) 390
mutation (388) 388
sensitivity and specificity (383) 383
classification (377) 377
pancreatic neoplasms (377) 377
cell biology (376) 376
gastroenterology (370) 370
genetic aspects (364) 364
review (363) 363
carcinoid-tumors (360) 360
medicine, general & internal (357) 357
neuroendocrine tumors - genetics (357) 357
liver (355) 355
metastases (353) 353
medical research (352) 352
pancreatic tumors (352) 352
survival rate (352) 352
survival analysis (350) 350
gene expression (346) 346
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (38) 38
Online Resources - Online (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10204) 10204
German (182) 182
Spanish (131) 131
Japanese (108) 108
French (100) 100
Chinese (53) 53
Korean (33) 33
Italian (28) 28
Russian (26) 26
Polish (24) 24
Hungarian (19) 19
Czech (10) 10
Portuguese (9) 9
Danish (8) 8
Swedish (6) 6
Dutch (5) 5
Turkish (5) 5
Croatian (4) 4
Serbian (4) 4
Finnish (3) 3
Bulgarian (2) 2
Greek (2) 2
Latvian (2) 2
Slovak (2) 2
Ukrainian (2) 2
Arabic (1) 1
Bosnian (1) 1
Norwegian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Gastroenteropancreatic neuroendocrine tumours
by Modlin, Irvin M, Prof and Oberg, Kjell, Prof and Chung, Daniel C, MD and Jensen, Robert T, MD and de Herder, Wouter W, MD and Thakker, Rajesh V, Prof and Caplin, Martyn, MD and Delle Fave, Gianfranco, Prof and Kaltsas, Greg A, MD and Krenning, Eric P, Prof and Moss, Steven F, MD and Nilsson, Ola, Prof and Rindi, Guido, MD and Salazar, Ramon, MD and Ruszniewski, Philippe, Prof and Sundin, Anders, MD and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Enheten för radiologi and Institutionen för onkologi, radiologi och klinisk immunologi and Uppsala universitet and Institutionen för medicinska vetenskaper
Lancet Oncology, The, ISSN 1470-2045, 2008, Volume 9, Issue 1, pp. 61 - 72
Summary Gastroenteropancreatic (GEP) neuroendocrine tumours (NETs) are fairly rare neoplasms that present many clinical challenges. They secrete peptides and... 
Hematology, Oncology and Palliative Medicine | LIVER METASTASES | SURVIVAL | POSITRON-EMISSION-TOMOGRAPHY | CELL TUMORS | CHEMOEMBOLIZATION | ONCOLOGY | MIDGUT CARCINOID-TUMORS | MULTIPLE ENDOCRINE NEOPLASIA | SOMATOSTATIN RECEPTOR SCINTIGRAPHY | ZOLLINGER-ELLISON-SYNDROME | SURGICAL-TREATMENT | Carcinoma, Neuroendocrine - metabolism | Somatostatin - analogs & derivatives | Pancreatic Neoplasms - metabolism | Molecular Biology | Carcinoma, Neuroendocrine - classification | Humans | Gastrointestinal Neoplasms - therapy | Biomarkers, Tumor | Animals | Carcinoma, Neuroendocrine - pathology | Pancreatic Neoplasms - physiopathology | Somatostatin - therapeutic use | Gastrointestinal Neoplasms - physiopathology | Somatostatin - metabolism | Gastrointestinal Neoplasms - metabolism | Pancreatic Neoplasms - therapy | Protein-Tyrosine Kinases - antagonists & inhibitors | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Neuroendocrine tumors, version 1.2015
by Kulke, Matthew H and Shah, Manisha H and Benson, Al B and Bergsland, Emily and Berlin, Jordan D and Blaszkowsky, Lawrence S and Emerson, Lyska and Engstrom, Paul F and Fanta, Paul and Giordano, Thomas and Goldner, Whitney S and Halfdanarson, Thorvardur R and Heslin, Martin J and Kandeel, Fouad and Kunz, Pamela L and Kuvshinoff, Boris W and Lieu, Christopher and Moley, Jeffrey F and Munene, Gitonga and Pillarisetty, Venu G and Saltz, Leonard and Sosa, Julie Ann and Strosberg, Jonathan R and Vauthey, Jean-Nicolas and Wolfgang, Christopher and Yao, James C and Burns, Jennifer and Freedman-Cass, Deborah and National comprehensive cancer network
JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 01/2015, Volume 13, Issue 1, pp. 78 - 108
Neuroendocrine tumors (NETs) comprise a broad family of tumors that may or may not be associated with symptoms attributable to hormonal hypersecretion. The... 
RADIOLABELED SOMATOSTATIN ANALOG | PANCREATIC ENDOCRINE TUMORS | LIVER-TRANSPLANTATION | MALIGNANT CARCINOID-SYNDROME | PROGNOSTIC-FACTORS | ONCOLOGY | TREATMENT-RELATED MORTALITY | LONG-TERM SURVIVAL | HEPATIC ARTERIAL CHEMOEMBOLIZATION | CHROMOGRANIN-A | PROLONGED-RELEASE LANREOTIDE | Disease Management | Neuroendocrine Tumors - diagnosis | Neuroendocrine Tumors - therapy | Humans
Journal Article
Details down arrow
3. Full Text Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
by Caplin, Martyn E and Pavel, Marianne and Ćwikła, Jarosław B and Phan, Alexandria T and Raderer, Markus and Sedláčková, Eva and Cadiot, Guillaume and Wolin, Edward M and Capdevila, Jaume and Wall, Lucy and Rindi, Guido and Langley, Alison and Martinez, Séverine and Blumberg, Joëlle and Ruszniewski, Philippe and CLARINET Investigators
The New England Journal of Medicine, ISSN 0028-4793, 07/2014, Volume 371, Issue 3, pp. 224 - 233
As compared with placebo, extended-release lanreotide (120 mg every 28 days) was associated with delayed disease progression in patients with nonfunctional,... 
STREPTOZOCIN | MEDICINE, GENERAL & INTERNAL | SOMATOSTATIN ANALOGS | EVEROLIMUS | EFFICACY | CARCINOID-SYNDROME | GUIDELINES | DOXORUBICIN | AUTOGEL | FLUOROURACIL | COOPERATIVE-ONCOLOGY-GROUP | Somatostatin - analogs & derivatives | Double-Blind Method | Somatostatin - adverse effects | Gastrointestinal Neoplasms - drug therapy | Humans | Middle Aged | Pancreatic Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Pancreatic Neoplasms - drug therapy | Disease-Free Survival | Gastrointestinal Neoplasms - pathology | Antineoplastic Agents - adverse effects | Neuroendocrine Tumors - secondary | Neuroendocrine Tumors - mortality | Neuroendocrine Tumors - drug therapy | Peptides, Cyclic - therapeutic use | Diarrhea - etiology | Female | Aged | Somatostatin - therapeutic use | Delayed-Action Preparations | Peptides, Cyclic - adverse effects | Lanreotide | Dosage and administration | Antigens | Hindgut | Midgut | Liver | Diarrhea | Metastasis | Patients | Survival | Quality of life | Metastases | Antitumor activity | Somatostatin | Solid tumors | Pancreas | Drug therapy | Neuroendocrine tumors | Tumors | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Pancreatic neuroendocrine tumors
by Hill, Joshua S and McPhee, James T and McDade, Theodore P and Zhou, Zheng and Sullivan, Mary E and Whalen, Giles F and Tseng, Jennifer F
Cancer, ISSN 0008-543X, 02/2009, Volume 115, Issue 4, pp. 741 - 751
BACKGROUND: Although surgical resection is generally recommended for patients with localized pancreatic neuroendocrine tumors (PNETs), the impact of resection... 
Survival advantage | Pancreatic neuroendocrine tumors | End results (seer) database | Pancreatic resection | Surveillance | Epidemiology | SURVIVAL | POPULATION | ISLET-CELL CARCINOMA | RESECTION | End Results (SEER) database | ZOLLINGER-ELLISON-SYNDROME | SURGICAL-TREATMENT | survival advantage | pancreatic neuroendocrine tumors | HEPATIC METASTASES | ONCOLOGY | AGGRESSIVE SURGERY | LIVER | EXPERIENCE | pancreatic resection
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Neuroendocrine tumours
by M T Barakat and K Meeran and S R Bloom
Endocrine-Related Cancer, ISSN 1351-0088, 03/2004, Volume 11, Issue 1, pp. 1 - 18
Neuroendocrine tumours are a heterogeneous group including, for example, carcinoid, gastroenteropancreatic neuroendocrine tumours, pituitary tumours, medullary... 
SELECTIVE INTRAARTERIAL INJECTION | ONCOLOGY | PANCREATIC TUMORS | CARCINOID-TUMORS | ENDOCRINOLOGY & METABOLISM | GASTROENTEROPANCREATIC TUMORS | ISLET CELL TUMORS | ENDOSCOPIC ULTRASONOGRAPHY | SOMATOSTATIN RECEPTOR SCINTIGRAPHY | ZOLLINGER-ELLISON-SYNDROME | ENDOCRINE NEOPLASIA TYPE-1 | HEPATIC-ARTERY EMBOLIZATION | Carcinoid Tumor - etiology | Biomarkers, Tumor - analysis | Pheochromocytoma - diagnosis | Pheochromocytoma - etiology | Humans | Neuroendocrine Tumors - diagnosis | Multiple Endocrine Neoplasia - diagnosis | Syndrome | Carcinoid Tumor - therapy | Multiple Endocrine Neoplasia - etiology | Multiple Endocrine Neoplasia - therapy | Neuroendocrine Tumors - therapy | Neuroendocrine Tumors - etiology | Carcinoid Tumor - diagnosis | Pheochromocytoma - therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Everolimus for Advanced Pancreatic Neuroendocrine Tumors
by Yao, James C and Shah, Manisha H and Ito, Tetsuhide and Bohas, Catherine Lombard and Wolin, Edward M and Van Cutsem, Eric and Hobday, Timothy J and Okusaka, Takuji and Capdevila, Jaume and de Vries, Elisabeth G.E and Tomassetti, Paola and Pavel, Marianne E and Hoosen, Sakina and Haas, Tomas and Lincy, Jeremie and Lebwohl, David and Öberg, Kjell and RAD001 Adv Neuroendocrine Tumors T and RAD001 in Advanced Neuroendocrine Tumors, Third Trial (RADIANT-3) Study Group and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Institutionen för medicinska vetenskaper and Medicin
The New England Journal of Medicine, ISSN 0028-4793, 02/2011, Volume 364, Issue 6, pp. 514 - 523
A randomized study involving 410 patients with advanced pancreatic neuroendocrine tumors showed that everolimus, as compared with placebo, more than doubled... 
STREPTOZOCIN | MEDICINE, GENERAL & INTERNAL | ISLET-CELL-CARCINOMA | SOLID TUMORS | EFFICACY | DOXORUBICIN | ENDOCRINE TUMORS | PHASE-II | ANTITUMOR-ACTIVITY | FLUOROURACIL | COMBINATION | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Double-Blind Method | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Antineoplastic Agents - therapeutic use | Disease Progression | Pancreatic Neoplasms - drug therapy | TOR Serine-Threonine Kinases - antagonists & inhibitors | Young Adult | Antineoplastic Agents - adverse effects | Protein Kinase Inhibitors - therapeutic use | Neuroendocrine Tumors - mortality | Aged, 80 and over | Neuroendocrine Tumors - drug therapy | Adult | Female | Aged | Pancreatic Neoplasms - mortality | Everolimus | Sirolimus - adverse effects | Radiology | Usage | Radiology, Medical | Drug therapy | Pancreatic tumors | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Consensus on biomarkers for neuroendocrine tumour disease
by Oberg, Kjell, Prof and Modlin, Irvin M, Prof and De Herder, Wouter, Prof and Pavel, Marianne, Prof and Klimstra, David, Prof and Frilling, Andrea, Prof and Metz, David C, Prof and Heaney, Anthony, MD and Kwekkeboom, Dik, MD and Strosberg, Jonathan, MD and Meyer, Timothy, Prof and Moss, Steven F, Prof and Washington, Kay, Prof and Wolin, Edward, Prof and Liu, Eric, MD and Goldenring, James, Prof and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Institutionen för medicinska vetenskaper
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 9, pp. e435 - e446
Summary Management of neuroendocrine neoplasia represents a clinical challenge because of its late presentation, lack of treatment options, and limitations in... 
Hematology, Oncology and Palliative Medicine | PROGASTRIN-RELEASING PEPTIDE | BREAST-CANCER | PANCREATIC ENDOCRINE TUMORS | PLASMA | ONCOLOGY | NEURON-SPECIFIC ENOLASE | CARCINOID-TUMORS | PANCREASTATIN | GUIDELINES | CHROMOGRANIN-A | PROGNOSTIC MARKERS | Biomarkers, Tumor - blood | Neuroendocrine Tumors - pathology | Neuroendocrine Tumors - blood | Delphi Technique | Prognosis | United States | Humans | Neoplastic Cells, Circulating | National Cancer Institute (U.S.) | MicroRNAs - blood | Neuroendocrine Tumors - genetics | Biological markers | Medical colleges | Tumors | Metastasis | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Whole-genome landscape of pancreatic neuroendocrine tumours
by Scarpa, Aldo and Chang, David K and Nones, Katia and Corbo, Vincenzo and Patch, Ann-Marie and Bailey, Peter and Lawlor, Rita T and Johns, Amber L and Miller, David K and Mafficini, Andrea and Rusev, Borislav and Scardoni, Maria and Antonello, Davide and Barbi, Stefano and Sikora, Katarzyna O and Cingarlini, Sara and Vicentini, Caterina and McKay, Skye and Quinn, Michael C.J and Bruxner, Timothy J.C and Christ, Angelika N and Harliwong, Ivon and Idrisoglu, Senel and McLean, Suzanne and Nourse, Craig and Nourbakhsh, Ehsan and Wilson, Peter J and Anderson, Matthew J and Fink, J. Lynn and Newell, Felicity and Waddell, Nick and Holmes, Oliver and Kazakoff, Stephen H and Leonard, Conrad and Wood, Scott and Xu, Qinying and Nagaraj, Shivashankar Hiriyur and Amato, Eliana and Dalai, Irene and Bersani, Samantha and Cataldo, Ivana and Dei Tos, Angelo P and Capelli, Paola and Davì, Maria Vittoria and Landoni, Luca and Malpaga, Anna and Miotto, Marco and Whitehall, Vicki L.J and Leggett, Barbara A and Harris, Janelle L and Harris, Jonathan and Jones, Marc D and Humphris, Jeremy and Chantrill, Lorraine A and Chin, Venessa and Nagrial, Adnan M and Pajic, Marina and Scarlett, Christopher J and Pinho, Andreia and Rooman, Ilse and Toon, Christopher and Wu, Jianmin and Pinese, Mark and Cowley, Mark and Barbour, Andrew and Mawson, Amanda and Humphrey, Emily S and Colvin, Emily K and Chou, Angela and Lovell, Jessica A and Jamieson, Nigel B and Duthie, Fraser and Gingras, Marie-Claude and Fisher, William E and Dagg, Rebecca A and Lau, Loretta M.S and Lee, Michael and Pickett, Hilda A and Reddel, Roger R and Samra, Jaswinder S and Kench, James G and Merrett, Neil D and Epari, Krishna and Nguyen, Nam Q and Zeps, Nikolajs and Falconi, Massimo and Simbolo, Michele and Butturini, Giovanni and Van Buren, George and Partelli, Stefano and Fassan, Matteo and Khanna, Kum Kum and Gill, Anthony J and Wheeler, David A and Gibbs, Richard A and Musgrove, Elizabeth A and Bassi, Claudio and Tortora, Giampaolo and Pederzoli, Paolo and Pearson, John V and ... and Australian Pancreatic Canc Genome and Australian Pancreatic Cancer Genome Initiative
Nature, ISSN 0028-0836, 03/2017, Volume 543, Issue 7643, pp. 65 - 71
The diagnosis of pancreatic neuroendocrine tumours (PanNETs) is increasing owing to more sensitive detection methods, and this increase is creating challenges... 
MOLECULAR SUBTYPES | MUTATIONAL PROCESSES | TRANSLOCATION | SUPPRESSOR | PROTEIN | PATHWAY GENES | MULTIDISCIPLINARY SCIENCES | MTOR PATHWAY | TP53 MUTATIONS | CANCER | EWING SARCOMA | Calmodulin-Binding Proteins - genetics | RNA-Binding Proteins - genetics | TOR Serine-Threonine Kinases - metabolism | Genomics | Humans | DNA Glycosylases - genetics | Carcinoma, Neuroendocrine - genetics | Chromatin Assembly and Disassembly - genetics | Male | Pancreatic Neoplasms - genetics | DNA Copy Number Variations - genetics | DNA Repair - genetics | Germ-Line Mutation - genetics | Genome, Human - genetics | DNA Mutational Analysis | Base Sequence | Chromosome Aberrations | Female | Telomere - metabolism | RNA-Binding Protein EWS | Telomere - genetics | Genetic aspects | Nucleotide sequencing | Pancreatic cancer | Methods | DNA sequencing | Genes | Biomarkers | Genomes | Mutation | Signatures | Patients | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Neuroendocrine Tumors
by Basuroy, Ron and Srirajaskanthan, Raj and Ramage, John K
Gastroenterology Clinics of North America, ISSN 0889-8553, 09/2016, Volume 45, Issue 3, pp. 487 - 507
Neuroendocrine tumors are increasingly diagnosed, either incidentally as part of screening processes, or for symptoms, which have commonly been mistaken for... 
Therapy | Tumor | Carcinoid | Diagnostics | Multimodal | Neuroendocrine | METASTATIC CARCINOID-TUMORS | SOMATOSTATIN ANALOGS | PROGNOSTIC-FACTORS | LONG-TERM OUTCOMES | GASTROINTESTINAL-TRACT | HEPATIC ARTERIAL CHEMOEMBOLIZATION | CHROMOGRANIN-A | LIVER METASTASES | PHASE-II TRIAL | RECEPTOR RADIONUCLIDE THERAPY | GASTROENTEROLOGY & HEPATOLOGY | Pancreatic Neoplasms - metabolism | Pancreatic Neoplasms - diagnosis | Humans | Tomography, X-Ray Computed | Antineoplastic Agents - therapeutic use | Liver Neoplasms - therapy | Neuroendocrine Tumors - diagnosis | Embolization, Therapeutic | Organometallic Compounds | Gastrointestinal Neoplasms - pathology | Antineoplastic Agents, Hormonal - therapeutic use | Chromogranin A - metabolism | Receptors, Somatostatin - metabolism | Liver Neoplasms - secondary | Radiopharmaceuticals | Gastrointestinal Neoplasms - metabolism | Neuroendocrine Tumors - metabolism | Pancreatic Neoplasms - pathology | Hepatic Artery | Hydroxyindoleacetic Acid - metabolism | Gastrointestinal Neoplasms - diagnosis | Gastrointestinal Neoplasms - therapy | Octreotide - therapeutic use | Malignant Carcinoid Syndrome - therapy | Positron Emission Tomography Computed Tomography | Magnetic Resonance Imaging | Metastasectomy | Digestive System Surgical Procedures | Neuroendocrine Tumors - secondary | Serotonin - metabolism | Gallium Radioisotopes | Fluorodeoxyglucose F18 | Neuroendocrine Tumors - therapy | Neoplasm Staging | Pancreatic Neoplasms - therapy
Journal Article
Details down arrow
10. Full Text Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
by Ozdemir, Nuriye and Yazici, Ozan and Zengin, Nurullah and Yang, Feng and Jin, Chen and Fu, Deliang and Caplin, Martyn E and Pavel, Marianne and Ruszniewski, Philippe
The New England Journal of Medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 16, pp. 1555 - 1557
To the Editor: In the Controlled Study of Lanreotide Antiproliferative Response in Neuroendocrine Tumors (CLARINET), Caplin et al. (July 17 issue) 1 report... 
MEDICINE, GENERAL & INTERNAL | PET | SCINTIGRAPHY | Pancreatic Neoplasms - drug therapy | Somatostatin - analogs & derivatives | Gastrointestinal Neoplasms - drug therapy | Humans | Neuroendocrine Tumors - drug therapy | Peptides, Cyclic - therapeutic use | Female | Male | Antineoplastic Agents - therapeutic use | Tomography | Octreotide | Scintigraphy | Somatostatin | Somatostatin receptors | Neuroendocrine tumors | Metastases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Neuroendocrine tumor disease: An evolving landscape
by Frilling, Andrea and Åkerström, Goran and Falconi, Massimo and Pavel, Marianne and Ramos, Jose and Kidd, Mark and Modlin, Irvin Mark and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Endokrinkirurgi and Institutionen för kirurgiska vetenskaper
Endocrine-Related Cancer, ISSN 1351-0088, 10/2012, Volume 19, Issue 5, pp. R163 - R185
Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) represent a heterogenous group of tumors arising from a variety of neuroendocrine cell types. The... 
RADIOLABELED SOMATOSTATIN ANALOG | NEOPLASIA TYPE-1 | SINGLE-CENTER EXPERIENCE | PANCREATIC ENDOCRINE TUMORS | LIVER-TRANSPLANTATION | ONCOLOGY | ENETS CONSENSUS GUIDELINES | MIDGUT CARCINOID-TUMORS | ENDOCRINOLOGY & METABOLISM | ISLET-CELL TUMORS | CHROMOGRANIN-A | ZOLLINGER-ELLISON-SYNDROME | Pancreatic Neoplasms - epidemiology | Pancreatic Neoplasms - metabolism | Neuroendocrine Tumors - metabolism | Pancreatic Neoplasms - diagnosis | Humans | Antineoplastic Agents - therapeutic use | Neuroendocrine Tumors - diagnosis | Neuroendocrine Tumors - epidemiology | Gastrointestinal Neoplasms - diagnosis | Gastrointestinal Neoplasms - therapy | Gastrointestinal Neoplasms - epidemiology | Biomarkers, Tumor - metabolism | Neuroendocrine Tumors - therapy | Gastrointestinal Neoplasms - metabolism | Pancreatic Neoplasms - therapy | dalotuzumab | temozolomide | Ki 67 antigen | Medical and Health Sciences | sorafenib | cancer surgery | antiproliferative activity | capecitabine | thalidomide | review | bevacizumab | cyclophosphamide | neuroendocrine tumor | protein expression | sunitinib | glucagonoma | liver metastasis | midgut neuroendocrine tumor | imatinib | cancer diagnosis | gefitinib | 5 hydroxyindoleacetic acid | vasculotropin antibody | somatostatin derivative | motesanib | cancer epidemiology | insulinoma | octreotide | gastrinoma | molecularly targeted therapy | Medicin och hälsovetenskap | pasireotide | tumor ablation | cancer grading | angiopeptin | delayed diagnosis | everolimus | gastric neuroendocrine tumor | human | vipoma | cancer combination chemotherapy | somatostatin receptor | gastroenteropancreatic neuroendocrine neoplasm | cancer localization | pazopanib | cancer prognosis | streptozocin | temsirolimus | pancreatic neuroendocrine tumor | treatment response | chromogranin A | drug efficacy | positron emission tomography | cancer incidence | lymph node metastasis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights